These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24254570)

  • 1. Efficacy of botulinum toxin A for treatment of unilateral spasms of the eyelid and its prognosis.
    Xu YP; Shen J; Zhu QB; Gu J; Lin SZ; Fan JP
    Eur Rev Med Pharmacol Sci; 2013 Nov; 17(21):2974-9. PubMed ID: 24254570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm.
    Wu CJ; Shen JH; Chen Y; Lian YJ
    Turk Neurosurg; 2011; 21(4):625-9. PubMed ID: 22194126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH; Cetinkaya A; Kulwin DR
    Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm.
    Cannon PS; MacKenzie KR; Cook AE; Leatherbarrow B
    Clin Exp Ophthalmol; 2010 Oct; 38(7):688-91. PubMed ID: 20456439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin treatment of hemifacial spasm and blepharospasm: objective response evaluation.
    Thussu A; Barman CR; Prabhakar S
    Neurol India; 1999 Sep; 47(3):206-9. PubMed ID: 10514580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study.
    Kongsengdao S; Kritalukkul S
    J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S48-54. PubMed ID: 22619887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of botulinum A toxin repeated injection in treating blepharospasm and hemifacial spasm].
    Wang J; Zhang X
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Apr; 20(7):292-4. PubMed ID: 16780139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes.
    Cillino S; Raimondi G; Guépratte N; Damiani S; Cillino M; Di Pace F; Casuccio A
    Eye (Lond); 2010 Apr; 24(4):600-7. PubMed ID: 19648904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative crossover study on the treatment of hemifacial spasm and blepharospasm: preseptal and pretarsal botulinum toxin injection techniques.
    Lolekha P; Choolam A; Kulkantrakorn K
    Neurol Sci; 2017 Nov; 38(11):2031-2036. PubMed ID: 28884242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome.
    Czyz CN; Burns JA; Petrie TP; Watkins JR; Cahill KV; Foster JA
    Am J Ophthalmol; 2013 Jul; 156(1):173-177.e2. PubMed ID: 23541393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Cakmur R; Ozturk V; Uzunel F; Donmez B; Idiman F
    J Neurol; 2002 Jan; 249(1):64-8. PubMed ID: 11954870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of involuntary eyelid spasms on corneal topographic and eyelid morphometric changes in patients with hemifacial spasm.
    Osaki T; Osaki MH; Osaki TH; Hirai FE; Nallasamy N; Campos M
    Br J Ophthalmol; 2016 Jul; 100(7):963-970. PubMed ID: 26541432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blepharospasm and hemifacial spasm: long-term treatment with botulinum toxin.
    Gil Polo C; Rodríguez Sanz MF; Berrocal Izquierdo N; Castrillo Sanz A; Gutiérrez Ríos R; Zamora García MI; Mendoza Rodríguez A; Duarte García-Luis J
    Neurologia; 2013 Apr; 28(3):131-6. PubMed ID: 22652139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose botulinum toxin a for treatment of blepharospasm and hemifacial spasm.
    Poonyathalang A; Preechawat P; Jamnansiri U
    Jpn J Ophthalmol; 2005; 49(4):327-8. PubMed ID: 16075337
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of carbamazepine combined with botulinum toxin a in the treatment of blepharospasm and hemifacial spasm.
    Li XH; Lin SC; Hu YF; Liu LY; Liu JB; Hong YC
    Eye Sci; 2012 Dec; 27(4):178-81. PubMed ID: 23225838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemifacial spasm: results of treatment with low dose botulinum toxin injection.
    Suputtitada A; Phanthumchinda K; Locharernkul C; Suwanwela NC
    J Med Assoc Thai; 2004 Oct; 87(10):1205-11. PubMed ID: 15560699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corneal and Tear Film Changes After Botulinum Toxin-A in Blepharospasm or Hemifacial Spasm.
    Gunes A; Demirci S; Koyuncuoglu HR; Tok L; Tok O
    Cornea; 2015 Aug; 34(8):906-10. PubMed ID: 26075455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Riolan's muscle: action and indications for botulinum toxin injection.
    Mackie IA
    Eye (Lond); 2000 Jun; 14 ( Pt 3A)():347-52. PubMed ID: 11026998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing the area and varying the dosage of Botulinum toxin a injections for effective treatment of hemifacial spasm.
    Choe WJ; Kim J
    Acta Otolaryngol; 2016 Sep; 136(9):952-5. PubMed ID: 27067535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
    Bihari K
    Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.